A study on the interferon-γ activated intracellular signal transduction pathway in the thyroid
甲状腺干扰素-γ激活细胞内信号转导通路的研究
基本信息
- 批准号:12671073
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
【IRF-1 study】Interferon regulatory factor-1 (IRF-1), an interferon (IFN)-inducible transcription factor, is expressed in the thyroid and implicated in the regulation of thyroid function and in the pathogenesis of autoimmune thyroid disease (AITD). To examine the role of IRF-1 in the development of AITD, the frequency and severity of thyroiditis were assessed in nonobese diabetic (NOD) mice, an animal model of Hashimoto's thyroiditis, lacking IRF-1 gene. While more than 80 % of 14 week-old iodide ingested IRF-1 +/+ and +/- mice developed lymphocytic thyroiditis (LT), no -/- mice developed LT. In contrast, 24 week-old mice and thyroglobulin (Tg)immunized mice developed thyroiditis regardless of IRF-1. In the latter, no significant difference was found in the severity of thyroiditis. In IRF-1 -/- mice, CD8+T cells and IFN-γ secretion were decreased in the spleen. These results suggest that CD8+ T cells and Th1 reaction are involved in the development of iodide-induced LT in IRF-1 deficient NOD mice. However, different mechanism may be involved in spontaneous and Tg-induced thyroiditis in NOD mice.【PKR study】Double-stranded RNA (dsRNA) dependent protein kinase (PKR) play a role in the antiviral responses as well as the regulation of cell function. We demonstrated the presence of PKR in FRTL-5 rat thyroid cells. Addition of dsRNA to FRTL-5 cells resulted in phosphorylation of eukaryotic initiation factor-2 and iκBα and induction of NFκB binding. In addition, type I IFN, especially IFN-β, and IRF-1 gene expression and STAT-1 phosphorylation were induced in dsRNA-stimulated cells. These results suggest that dsRNA activated signal transduction pathway may play a role in the regulation of thyroid function and may be involved in the pathogenesis of AITD.
【IRF-1研究】干扰素调节因子-1 (Interferon regulatory factor-1, IRF-1)是干扰素(IFN)诱导的转录因子,在甲状腺中表达,参与甲状腺功能的调节和自身免疫性甲状腺疾病(autoimmune thyroid disease, AITD)的发病机制。为了研究IRF-1在AITD发展中的作用,我们在缺乏IRF-1基因的桥本甲状腺炎动物模型非肥胖糖尿病(NOD)小鼠中评估了甲状腺炎的频率和严重程度。虽然超过80%的14周龄碘摄入IRF-1 +/+和+/-小鼠发生淋巴细胞性甲状腺炎(LT),但没有-/-小鼠发生LT。相反,24周龄小鼠和免疫甲状腺球蛋白(Tg)的小鼠发生甲状腺炎,无论IRF-1是否存在。在后者中,甲状腺炎的严重程度无显著差异。在IRF-1 -/-小鼠中,脾脏中CD8+T细胞和IFN-γ分泌减少。这些结果表明,CD8+ T细胞和Th1反应参与了IRF-1缺陷NOD小鼠碘诱导的LT的发展。然而,NOD小鼠自发性甲状腺炎和tg诱导的甲状腺炎可能涉及不同的机制。【PKR研究】双链RNA (dsRNA)依赖性蛋白激酶(PKR)在抗病毒应答和细胞功能调控中发挥重要作用。我们证实PKR存在于FRTL-5大鼠甲状腺细胞中。在FRTL-5细胞中添加dsRNA可导致真核起始因子-2和iκBα磷酸化,并诱导NFκB结合。此外,在dsrna刺激的细胞中,I型IFN,特别是IFN-β, IRF-1基因表达和STAT-1磷酸化被诱导。这些结果提示dsRNA激活的信号转导通路可能参与甲状腺功能的调节,并可能参与AITD的发病机制。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mori K,Yoshida K, et al: "Double-stranded RNA-induced expression of type I interferon in FRTL-5 rat thyroid cells"Endocr.J.. 47(Suppl). 219 (2000)
Mori K、Yoshida K 等人:“FRTL-5 大鼠甲状腺细胞中双链 RNA 诱导的 I 型干扰素表达”Endocr.J.. 47(增刊)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mori K, Yoshida K, Tani J, Nakagawa Y, Hoshikawa s, Ito S.: "Double-stranded RNA-induced interferon regulatory factor-1 gene expression in FRTL-5 rat thyroid cells"Molecular and Cellular Endocrinology. 184(1-2). 77-86 (2001)
Mori K、Yoshida K、Tani J、Nakakawa Y、Hoshikawa s、Ito S.:“FRTL-5 大鼠甲状腺细胞中双链 RNA 诱导的干扰素调节因子-1 基因表达”分子和细胞内分泌学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mori K, Yoshida K, Tani J, Nakagawa Y, Hoshikawa S, Ito S.: "Double-stranded RNA-induced interferon regulatory factor-1 gene expression in FRTL-5 rat thyroid cells"Molecular and Cellular Endocrinology. 184. 77-86 (2001)
Mori K、Yoshida K、Tani J、Nakakawa Y、Hoshikawa S、Ito S.:“FRTL-5 大鼠甲状腺细胞中双链 RNA 诱导的干扰素调节因子-1 基因表达”分子和细胞内分泌学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mori K, Yoshida K, Tani J, Nakagawa Y, Hoshikawa S, Ito S: "Double-stranded RNA-induced interferon regulatory factor-1 gene expression in FRTL-5 rat thyroid cells"Molecular and Cellular Endocrinology. 184 (1-2). 77-86 (2001)
Mori K、Yoshida K、Tani J、Nakakawa Y、Hoshikawa S、Ito S:“FRTL-5 大鼠甲状腺细胞中双链 RNA 诱导的干扰素调节因子-1 基因表达”分子和细胞内分泌学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MORI Koki其他文献
MORI Koki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Does chronic thyroid inflammation explain persistent symptoms in Hashimoto thyroiditis?
慢性甲状腺炎症是否可以解释桥本甲状腺炎的持续症状?
- 批准号:
MR/Z503617/1 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Research Grant
Macrophage-polarizing ALMA hydrogels for thyroid regeneration following radiation injury
巨噬细胞极化 ALMA 水凝胶用于放射损伤后甲状腺再生
- 批准号:
MR/Y033817/1 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Research Grant
Thyroid hormones and Pigmentation pattern evolution in clownfish
小丑鱼的甲状腺激素和色素沉着模式的演变
- 批准号:
23K23941 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Preoperative molecular diagnosis with novel follicular thyroid carcinoma-specific markers using cytology and blood samples
使用细胞学和血液样本进行新型滤泡性甲状腺癌特异性标记物的术前分子诊断
- 批准号:
23K08060 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exploration of biomarkers based on genomic information and tumor immune microenvironment of thyroid cancer
基于甲状腺癌基因组信息和肿瘤免疫微环境的生物标志物探索
- 批准号:
23K19516 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Optimizing Care for Older Adults through Thyroid Hormone Deprescribing
通过减少甲状腺激素处方来优化老年人的护理
- 批准号:
10733478 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
A Pilot Feasibility Study of an Intervention to Decrease Overtreatment of Low-risk Thyroid Cancer
减少低危甲状腺癌过度治疗的干预措施试点可行性研究
- 批准号:
10729147 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Thyroid Hormone Signaling in Human Hepatocytes
人肝细胞中的甲状腺激素信号传导
- 批准号:
10874207 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Thyroid Follicular Cell Signaling and Development in Humans
人类甲状腺滤泡细胞信号传导和发育
- 批准号:
10801642 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Hypothalamic regulation by thyroid hormone receptor phosphorylation
甲状腺激素受体磷酸化对下丘脑的调节
- 批准号:
10717820 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:














{{item.name}}会员




